Icahn School of Medicine: Scientists Unlock Promising Key to Preventing Cancer Relapse After Immunotherapy
December 18, 2020
December 18, 2020
NEW YORK, Dec. 18 (TNSJou) -- The Icahn School of Medicine at Mount Sinai issued the following news release:
Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not all the cells in those tumors have the molecular target that the therapy is aimed at?
The answer involves a protein called fas, and regulating fas may be a route to preventing cancer relapse, the resear . . .
Mount Sinai researchers have solved one of the enduring mysteries of cancer immunotherapy: Why does it completely eliminate tumors in many patients, even when not all the cells in those tumors have the molecular target that the therapy is aimed at?
The answer involves a protein called fas, and regulating fas may be a route to preventing cancer relapse, the resear . . .